Reset filters
  • 27 June 2011

Only modest benefits from starting HIV therapy with a CD4 cell count above 500 compared to 350

Read the article
  • 22 June 2011

Abacavir and cardiovascular risk: contradictory findings continue to emerge, mechanisms still unclear

Read the article
  • 2 June 2011

What do treatment as prevention study results mean for treatment?

Read the article
  • 31 May 2011

Long-term CD4 cell gains on treatment weaker in over-50s

Read the article
  • 23 May 2011

Rilpivirine (Edurant) approved in United States

Read the article
  • 11 May 2011

Local beliefs and ART programme factors both influence late ARV starts in sub-Saharan Africa

Read the article
  • 9 May 2011

First ever CD4 cell count after primary infection can predict immune restoration during HIV therapy

Read the article
  • 21 April 2011

Starting HIV treatment when CD4 cell count dips below 500 improves AIDS-free survival

Read the article
  • 20 April 2011

Some London clinics may have difficulty meeting drug prescription targets

Read the article

Receive the latest HIV research and conference news

Complete this form to receive regular email bulletins including the latest HIV research and conference news from aidsmap and/or updates from Terrence Higgins Trust.

Get regular email bulletins

Please let us know how you'd like to be contacted by ticking the options below.